Strategic partnerships Resilient Biotics has established collaborations with Novus International to co-develop novel feed solutions for immune health and respiratory challenges in pigs, signaling openness to B2B partnerships in animal health and potential cross-industry sales opportunities.

Animal health focus Current and recent activity centers on production animals and swine immunity, presenting a clear entry point for sales discussions with animal nutritionists, feed producers, and veterinary health organizations seeking microbiome-based respiratory health solutions.

Microbiome platform The company’s proprietary microbiome discovery platform integrating genomics, ML, and targeted in vitro assays highlights a capability stack that can be leveraged to position value propositions around safe, non-antibiotic therapeutics for respiratory infections in both humans and animals.

Leadership and expertise Key hires in bioinformatics and translational medicine, along with a collaboration history with CosmosID, indicate a strong emphasis on data-driven product development, which can be leveraged in negotiations with research-driven customers seeking robust scientific credibility.

Funding and traction Revenue of up to 10 million and total funding around 7.2 million, combined with ongoing partnerships, suggest a growth phase with available capacity for co-development deals, pilots, or early access programs with prospective enterprise customers.